Paper39596365
Highly Calibrated Relationship Between Bleomycin Concentrations and Facets of the Active Phase Fibrosis in Classical Mouse Bleomycin Model.
Kadam AH and 1 other. Int J Mol Sci, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Highly Calibrated Relationship Between Bleomycin Concentrations and Facets of the Active Phase Fibrosis in Classical Mouse Bleomycin Model. Papers, record 39596365. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39596365
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Highly Calibrated Relationship Between Bleomycin Concentrations and Facets of the Active Phase Fibrosis in Classical Mouse Bleomycin Model.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bleomycin | Major topic |
| Disease Models, Animal | Major topic |
| Pulmonary Fibrosis | Major topic |
| Animals | |
| Mice | |
| Biomarkers | |
| Lung | |
| Mice, Inbred C57BL | |
| Collagen | |
| Bronchoalveolar Lavage Fluid | |
| Dose-Response Relationship, Drug | |
| Male |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 HL119165 | NHLBI NIH HHS | United States | P01HL119165 | PubMed | NIH RePORTER |
| R01 HL169760 | NHLBI NIH HHS | United States | R01HL169760 | PubMed | NIH RePORTER |
| P01HL119165 | National Institute of Health | P01HL119165 | PubMed | NIH RePORTER | |
| R01HL169760 | National Institute of Health | R01HL169760 | PubMed | NIH RePORTER |
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16415276 | Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. | Am J Respir Crit Care Med | 2006 | https://conductscience.org/library/papers/16415276 | PubMed |
| 2 | 23741300 | The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis. | PLoS One | 2013 | https://conductscience.org/library/papers/23741300 | PubMed |
| 3 | 11177318 | Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. | Ann Intern Med | 2001 | https://conductscience.org/library/papers/11177318 | PubMed |
| 4 | 37980896 | Progression of Acute Lung Injury in Intratracheal LPS Rat Model: Efficacy of Fluticasone, Dexamethasone, and Pirfenidone. | Pharmacology | 2024 | https://conductscience.org/library/papers/37980896 | PubMed |
| 5 | 28004808 | IL-13 is a therapeutic target in radiation lung injury. | Sci Rep | 2016 | https://conductscience.org/library/papers/28004808 | PubMed |
| 6 | 29740320 | Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/29740320 | PubMed |
| 7 | 18478089 | Functional Wnt signaling is increased in idiopathic pulmonary fibrosis. | PLoS One | 2008 | https://conductscience.org/library/papers/18478089 | PubMed |
| 8 | 16155090 | Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice. | Am J Physiol Lung Cell Mol Physiol | 2006 | https://conductscience.org/library/papers/16155090 | PubMed |
| 9 | 12383190 | Time course of bleomycin-induced lung fibrosis. | Int J Exp Pathol | 2002 | https://conductscience.org/library/papers/12383190 | PubMed |
| 10 | 3366935 | Simple method of estimating severity of pulmonary fibrosis on a numerical scale. | J Clin Pathol | 1988 | https://conductscience.org/library/papers/3366935 | PubMed |
| 11 | 26209236 | Pharmacological In Vivo Inhibition of S-Nitrosoglutathione Reductase Attenuates Bleomycin-Induced Inflammation and Fibrosis. | J Pharmacol Exp Ther | 2015 | https://conductscience.org/library/papers/26209236 | PubMed |
| 12 | 22684844 | Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis. | EMBO Mol Med | 2012 | https://conductscience.org/library/papers/22684844 | PubMed |
| 13 | 15684285 | Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury. | Eur Respir J | 2005 | https://conductscience.org/library/papers/15684285 | PubMed |
| 14 | 24507087 | Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis. | Respir Res | 2014 | https://conductscience.org/library/papers/24507087 | PubMed |
| 15 | 29795645 | Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol. | PLoS One | 2018 | https://conductscience.org/library/papers/29795645 | PubMed |
| 16 | 20649573 | A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. | Br J Pharmacol | 2010 | https://conductscience.org/library/papers/20649573 | PubMed |
| 17 | 30186404 | Pirfenidone suppresses bleomycin-induced pulmonary fibrosis and periostin expression in rats. | Exp Ther Med | 2018 | https://conductscience.org/library/papers/30186404 | PubMed |
| 18 | 29782549 | Sphingosine-1-phosphate receptor-2 facilitates pulmonary fibrosis through potentiating IL-13 pathway in macrophages. | PLoS One | 2018 | https://conductscience.org/library/papers/29782549 | PubMed |
| 19 | 23667616 | Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology. | PLoS One | 2013 | https://conductscience.org/library/papers/23667616 | PubMed |
| 20 | 24742272 | Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis. | BMC Pulm Med | 2014 | https://conductscience.org/library/papers/24742272 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42792632 | Broad-Spectrum Protective Effects of Lyophilized FE002-Lu Lung Fibroblast Conditioned Medium Against Acute and Chronic Pulmonary Injury in Wistar Rats. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792632 | PubMed |
| 42528868 | The IL-33-ILC2 axis: a key regulator of type 2 immunity in respiratory disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42528868 | PubMed |
| 42436598 | A novel two-hit murine model of inhaled occupational exposure-induced lung disease. | Physiol Rep | 2026 | https://conductscience.org/library/papers/42436598 | PubMed |
| 42230731 | Inhibition of runt related transcription factor 1 with Ro24-7429 improves lung function in experimental models of idiopathic pulmonary fibrosis. | Sci Rep | 2026 | https://conductscience.org/library/papers/42230731 | PubMed |
| 42168339 | Development of a translational murine model for antibody-drug conjugate-induced interstitial lung disease. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42168339 | PubMed |
| 42072279 | Interobserver Variability and Histopathologic Correlation of Lung Ultrasonography in a Bleomycin-Induced Mouse Model of Systemic Sclerosis. | Biomedicines | 2026 | https://conductscience.org/library/papers/42072279 | PubMed |
| 41394128 | Different degrees of expression of pulmonary fibrosis signs with intratracheal administration of bleomycin at different doses in male SD rats (a study aimed at helping to select the optimal bleomycin dose for modeling pulmonary fibrosis). | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41394128 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39596365
GET https://conductscience.org/api/papers/v1/39596365/references?page=2